Stocks were indicated to open handily lower on Tuesday after President Trump signaled that maybe a trade deal after the 2020 election might be best. Stocks already traded lower on Monday after negative trade-deal news and manufacturing data were digested, but that’s still after all major equity indexes hit all-time highs last week.
Investors are starting to see upside targets being issued for 2020, but many pressing issues and risks remain now that the bull market is over 10 and a half years old. This is a time for investors to consider what changes they should be making to their portfolios and assets as 2019 winds down and 2020 approaches.
24/7 Wall St. reviews dozens of analyst research reports each day of the week. Our goal is to find new ideas for traders and long-term investors alike. Some of the daily analyst calls cover stocks to buy, while some cover stocks to sell or to avoid.
We have provided these calls in a quick-hit summary for easy reading, and additional comments and trading data have been added on some calls. The consensus analyst price targets and other valuation metrics are from the Refinitiv sell-side research service.
These are the top analyst upgrades, downgrades and initiations for Tuesday, December 3, 2019.
Advanced Drainage Systems Inc. (NYSE: WMS) was started with a Buy rating and a $46 price objective (versus a $37.78 prior close) at Merrill Lynch.
Alphabet Inc. (NASDAQ: GOOGL) was started with an Overweight rating and a $1,500 price target at Piper Jaffray, and Citigroup assumed coverage as Buy with a $1,500 target, up from a prior $1,450.
Amazon.com Inc. (NASDAQ: AMZN) was assumed with a $2,200 price target and a Buy rating at Citigroup. Amazon closed down 1% at $1,781.60 on Monday, with a $2,167.56 consensus target price.
Ambev S.A. (NYSE: ABEV) was downgraded to Underweight from Equal Weight at Barclays. It closed up 0.7% at $4.24 on Monday, with a consensus target price of $5.21.
Anaplan Inc. (NYSE: PLAN) was named as the Bull of the Day at Zacks, which said that this mid-cap tech company has been posting double-digit revenue growth. Its shares most recently closed at $51.26 and have a consensus price target of $65.00.
Audentes Therapeutics Inc. (NASDAQ: BOLD) was last seen up just over 100% at $59.00 after it agreed to be acquired by Astellas for $60 per share in cash. Raymond James downgraded it to Market Perform from Outperform. Wedbush Securities downgraded it to Neutral from Outperform and H.C. Wainwright downgraded it to Neutral from Buy. Piper Jaffray and Guggenheim cut their ratings to Neutral, while Robert W. Baird raised the shares to Neutral from Underperform.
Bandwidth Inc. (NASDAQ: BAND) was started with a Buy rating and a $65 target price (versus a $53.44 close, after a 4.4% drop) at Needham.
Beyond Meat Inc. (NASDAQ: BYND) was started with a Perform rating at Oppenheimer. The stock closed at $79.27 and still has a consensus target price of $109.54.
Boston Beer Co. Inc. (NYSE: SAM) was raised to Buy from Neutral and its target price was raised to $440 from $415 (versus a $373.12 close, after a 2.9% drop) at UBS.